![]() |
產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號(hào) | CS11211 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS編號(hào) | |
抗體名 | Anti-Rb/P105 RB |
克隆性 | |
靶點(diǎn) | 詳見(jiàn)說(shuō)明書 |
適應(yīng)物種 | 詳見(jiàn)說(shuō)明書 |
形態(tài) | 詳見(jiàn)說(shuō)明書 |
宿主 | 詳見(jiàn)說(shuō)明書 |
亞型 | IgG |
標(biāo)識(shí)物 | 詳見(jiàn)說(shuō)明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human Rb/P105 RB |
技術(shù)外包服務(wù):
★成視網(wǎng)膜細(xì)胞瘤基因抗體品牌 分子生物學(xué):質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué):基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程:原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝:腺病毒、慢病毒等
★抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程:細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
實(shí)驗(yàn)流程:
成視網(wǎng)膜細(xì)胞瘤基因抗體品牌 英文名稱 Anti-Rb/P105 RB
中文名稱 成視網(wǎng)膜細(xì)胞瘤基因抗體品牌
別 名 OSRC; P105 RB; P105RB; PP105; PP110; pRb; RB 1; RB1; RB1 protein; Retinoblastoma 1 (including osteosarcoma); Retinoblastoma 1; Retinoblastoma associated protein; Retinoblastoma related osteosarcoma; Retinoblastoma susceptibility gene; RB_HUMAN.
產(chǎn)品屬性:
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Pig, Cow, Horse, Rabbit
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 免疫學(xué) 細(xì)胞凋亡 細(xì)胞周期蛋白
蛋白分子量 predicted molecular weight: 102kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Rb/P105 RB
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
成視網(wǎng)膜細(xì)胞瘤基因抗體品牌 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Nuclear Marker
The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma.
Rb is a tumor suppressor gene which functions as a negative regulator of the cell cycle by interacting with transcription factors including E2F1, PU1, ATF2, UBF, Elf1 and cAbl. This ability of Rb to alter transcription is regulated by phosphorylation catalyzed by the cyclin dependent protein kinases (cdks). Rb is phosphorylated on serine and threonine, but not on tyrosine residues. It forms a complex with SV40 large T antigen, adenovirus E1A, and human papilloma virus 16E. Rb protein may act by regulating transcription and loss of its function leads to uncontrolled cell growth. Aberrations in the Rb gene have been implicated in cancers of breast, colon, prostate, kidney, nasopharynx, and leukemia.
Function : Key regulator of entry into cell division that acts as a tumor suppressor. Promotes G0-G1 transition when phosphorylated by CDK3/cyclin-C. Acts as a transcription repressor of E2F1 target genes. The underphosphorylated, active form of RB1 interacts with E2F1 and represses its transcription activity, leading to cell cycle arrest. Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases SUV39H1, SUV420H1 and SUV420H2, leading to epigenetic transcriptional repression. Controls histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a histone deacetylase (HDAC) complex to the c-FOS promoter. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex (By similarity). In case of viral infections, interactions with SV40 large T antigen, HPV E7 protein or adenovirus E1A protein induce the disassembly of RB1-E2F1 complex thereby disrupting RB1's activity.
Subunit : nteracts with ATAD5. Interacts with PRMT2, CDK1 and CDK2. The hypophosphorylated form interacts with and sequesters the E2F1 transcription factor. Interacts with heterodimeric E2F/DP transcription factor complexes containing TFDP1 and either E2F1, E2F3, E2F4 or E2F5, or TFDP2 and E2F4. The unphosphorylated form interacts with EID1, ARID3B, KDM5A, SUV39H1, MJD2A/JHDM3A and THOC1. Interacts with the N-terminal domain of TAF1. Interacts with AATF, DNMT1, LIN9, LMNA, SUV420H1, SUV420H2, PELP1 and TMPO-alpha. May interact with NDC80. Interacts with GRIP1 and UBR4. Interacts with ARID4A and KDM5B. Interacts with E4F1 and LIMD1. Interacts with SMARCA4/BRG1 AND HDAC1. Interacts with adenovirus E1A protein, HPV E7 protein and SV40 large T antigen. Interacts with PSMA3 and USP4. Interacts (when methylated at Lys-860) with L3MBTL1.
Subcellular Location : Nucleus.
Tissue Specificity : Expressed in the retina.
Post-translational modifications : Phosphorylated by CDK6 and CDK4, and subsequently by CDK2 at Ser-567 in G1, thereby releasing E2F1 which is then able to activate cell growth. Dephosphorylated at the late M phase. SV40 large T antigen, HPV E7 and adenovirus E1A bind to the underphosphorylated, active form of pRb. Phosphorylation at Thr-821 and Thr-826 promotes interaction between the C-terminal domain C and the Pocket domain, and thereby inhibits interactions with heterodimeric E2F/DP transcription factor complexes. Dephosphorylated at Ser-795 by calcineruin upon calcium stimulation. CDK3/cyclin-C-mediated phosphorylation at Ser-807 and Ser-811 is required for G0-G1 transition. Phosphorylated by CDK1 and CDK2 upon TGFB1-mediated apoptosis.
N-terminus is methylated by METTL11A/NTM1. Monomethylated at Lys-860 by SMYD2, promoting interaction with L3MBTL1.
DISEASE : Defects in RB1 are the cause of childhood cancer retinoblastoma (RB) [MIM:180200]. RB is a congenital malignant tumor that arises from the nuclear layers of the retina. It occurs in about 1:20'000 live births and represents about 2% of childhood malignancies. It is bilateral in about 30% of cases. Although most RB appear sporadically, about 20% are transmitted as an autosomal dominant trait with incomplete penetrance. The diagnosis is usually made before the age of 2 years when strabismus or a gray to yellow reflex from pupil ('cat eye') is investigated.
Defects in RB1 are a cause of susceptibility to bladder cancer (BLC) [MIM:109800]. A malignancy originating in tissues of the urinary bladder. It often presents with multiple tumors appearing at different times and at different sites in the bladder. Most bladder cancers are transitional cell carcinomas. They begin in cells that normally make up the inner lining of the bladder. Other types of bladder cancer include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Bladder cancer is a complex disorder with both genetic and environmental influences.
Defects in RB1 are a cause of osteogenic sarcoma (OSRC) [MIM:259500].
Similarity : Belongs to the retinoblastoma protein (RB) family.
Database links :
UniProtKB/Swiss-Prot: P06400.2
Entrez Gene: 5925 Human
Entrez Gene: 19645 Mouse
Entrez Gene: 24708 Rat
Omim: 614041 Human
SwissProt: P06400 Human
SwissProt: P13405 Mouse
SwissProt: P33568 Rat
Unigene: 408528 Human
全、新、優(yōu)、品、好四大特點(diǎn):
成視網(wǎng)膜細(xì)胞瘤基因抗體品牌 全:公司提供上萬(wàn)種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細(xì)胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
好:我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì),產(chǎn)品一旦售出,實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。
正在熱銷的相關(guān)產(chǎn)品:
L-HDC (L-Histidine decarboxylase) L-組氨酸脫羧酶抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-Angiotensin II type 1A receptor 緊張素Ⅱ1A型受體抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh phospho-CaMK2 alpha (Thr305) 磷酸化鈣/鈣調(diào)素依賴蛋白激酶2α抗體 規(guī)格 0.1ml
過(guò)氧化物酶阻斷劑B 10ml 推薦用于石蠟切片,孵育10分鐘.
VHLH 英文名稱: 腦視網(wǎng)膜G7蛋白抗體(逢希伯-林道氏病) 0.2ml
Dbx2 英文名稱: 大腦發(fā)育同源蛋白2抗體 0.2ml
Anti-Angiotensin II type 1A receptor 緊張素Ⅱ1A型受體抗體Multi-class antibodies規(guī)格: 0.2ml
Anti-PI3K p85 (Tyr458)/p55 (Tyr199) /FITC 熒光素標(biāo)記磷酸化磷脂酰肌醇激酶抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rabbit Anti-human IgGF(ab')2 兔抗人IgGF(ab')2 (親和層析純化)Multi-class antibodies規(guī)格: 1mg
糖皮質(zhì)激素受體抗體 Anti-GR 0.1ml
Rabbit Anti-Bovine IgM/HRP 辣根過(guò)氧化物酶標(biāo)記的兔抗IgM 0.1ml
FRMD4B 英文名稱: FRMD4B蛋白抗體 0.2ml
Rhesus antibody Rh Phospho-SGK1 (Ser422) 磷酸化糖皮質(zhì)激素調(diào)節(jié)激酶1抗體 規(guī)格 0.1ml
Rabbit Anti-human IgGF(ab')2 兔抗人IgGF(ab')2 (親和層析純化)Multi-class antibodies規(guī)格: 1mg
SENP3 英文名稱: 類泛素蛋白3抗體 0.2ml
EMC1 英文名稱: 腺樣癌特異性相關(guān)抗原EMC1抗體 0.1ml
鋅指脂蛋白-1a抗體 Anti-ZNF268 - N-terminal Anti-ZNF268 - N-terminal 0.1ml
Anti-Tubb3/FITC 熒光素標(biāo)記β微管蛋白-Ⅲ抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh phospho-IKBKE(Thr501) 磷酸化核因子κB抑制蛋白E抗體 規(guī)格 0.1ml
TSHR (Thyroid stimulating hormone receptor)(NT) 促甲狀腺素受體(抗原)Multi-class antibodies規(guī)格: 0.5mg
BRL 3A, 大鼠肝正常細(xì)胞
COS-7 非洲綠猴SV40 轉(zhuǎn)化的腎細(xì)胞
VSIG2 Others Human 人 VSIG2 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CL-0014A-375(人惡性細(xì)胞)5×106cells/瓶×2
滋養(yǎng)層細(xì)胞生長(zhǎng)添加物TGS
EB病毒轉(zhuǎn)化的人B淋巴細(xì)胞;KM9801 人脈絡(luò)膜細(xì)胞完全培養(yǎng)基 100mL
CL-0087H4(人)5×106cells/瓶×2
IgG2 Others Human 人 IgG2-Fc (257 Ser/Ala) 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
小鼠直腸平滑肌細(xì)胞完全培養(yǎng)基 100mL
SV40 MES 13小鼠腎小球系膜細(xì)胞 SV40 MES 13 in mouse glomerular mesangial cells DMEM培養(yǎng)基+5%FBS
CF Protein Rat 重組大鼠 CF / Ciliary Neuroophic Factor 蛋白
SC-1(小鼠胚胎細(xì)胞) 5×106cells/瓶×2 K562(慢性髓原)
成視網(wǎng)膜細(xì)胞瘤基因抗體品牌 BRL 3A, 大鼠肝正常細(xì)胞
COS-7 非洲綠猴SV40 轉(zhuǎn)化的腎細(xì)胞
VSIG2 Others Human 人 VSIG2 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CL-0014A-375(人惡性細(xì)胞)5×106cells/瓶×2
滋養(yǎng)層細(xì)胞生長(zhǎng)添加物TGS
EB病毒轉(zhuǎn)化的人B淋巴細(xì)胞;KM9801 人脈絡(luò)膜細(xì)胞完全培養(yǎng)基 100mL